(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxy-phenyl)methylene]indolin-2-one

ID: ALA5285058

Max Phase: Preclinical

Molecular Formula: C15H9Br2NO3

Molecular Weight: 411.05

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1Nc2ccc(Br)cc2/C1=C/c1cc(O)c(O)c(Br)c1

Standard InChI:  InChI=1S/C15H9Br2NO3/c16-8-1-2-12-9(6-8)10(15(21)18-12)3-7-4-11(17)14(20)13(19)5-7/h1-6,19-20H,(H,18,21)/b10-3-

Standard InChI Key:  GPKLWRHHVIBYEO-KMKOMSMNSA-N

Molfile:  

 
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   -0.3924    2.0123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4325    2.0123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6827    1.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0291    0.7376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6383    1.2296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0025    2.6287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8241    2.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0747    1.6441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5076    1.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8881    1.4262    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.4516    1.0116    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0291   -0.1044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7000   -0.5254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7003   -1.3676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4277   -1.7867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1572   -1.3655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1588   -0.5276    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4324   -0.1026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4277   -2.6287    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8864   -1.7866    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8881   -0.1066    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  1  5  1  0
  5  4  1  0
  2  6  1  0
  7  6  2  0
  8  7  1  0
  9  8  2  0
  3  9  1  0
  8 10  1  0
  5 11  2  0
  4 12  2  0
 12 13  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 15 19  1  0
 16 20  1  0
 17 21  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5285058

    ---

Associated Targets(Human)

HTT Tchem Huntingtin (19182 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.05Molecular Weight (Monoisotopic): 408.8949AlogP: 4.12#Rotatable Bonds: 1
Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 7.61CX Basic pKa: CX LogP: 4.20CX LogD: 3.99
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.49Np Likeness Score: 0.07

References

1. Ahamad S, Bhat SA..  (2022)  The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease.,  65  (24.0): [PMID:36490325] [10.1021/acs.jmedchem.2c00799]

Source